| Citation: |
ZHANG Yue, TANG Xiaowei, XIAO Wenhuan, ZHAO Xiaoya. Correlations of serum epidermal growth factor and C-reactive protein with cognitive function in patients with schizophrenia[J]. Journal of Clinical Medicine in Practice, 2022, 26(11): 76-80, 86. DOI: 10.7619/jcmp.20215055
|
To investigate the relationships of serum epidermal growth factor (EGF), C-reactive protein (CRP) and their interactions with cognitive function in patients with schizophrenia.
According to the diagnostic criteria of Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-Ⅳ) for schizophrenia, 117 patients were recruited in this study.Patients'mental symptoms and cognitive function were assessed using the Positive and Negative Symptom Scale (PANSS) and Repeatable Battery for the Assessment of Neuropsychological Status (RBANS).Enzyme-linked immunosorbent assay (ELISA) and immunoturbidimetric method were used to detect the serum concentrations of EGF and CRP, respectively.The correlations of EGF and CRP with cognitive function were explored using correlation and hierarchical regression analysis.
Correlation analysis showed that EGF was significantly negatively correlated with CRP (r=-0.550, P < 0.001).hierarchical regression results showed that the interaction terms of EGF and CRP (β=0.411, t=4.436, P < 0.001) could predict visual span, and increase of 0.146 in the new model (R2=0.209) compared with the original model, showing the interaction item could explain 14.6% of the change of visual span.
The interactions between CRP and EGF may be related to the cognitive function in patients with schizophrenia, which is helpful to explore objective markers of cognitive deficits in schizophrenia.
| [1] |
WEISSLEDER C, WEBSTER M J, BARRY G, et al. Reduced insulin-like growth factor family member expression predicts neurogenesis marker expression in the subependymal zone in schizophrenia and bipolar disorder[J]. Schizophr Bull, 2021, 47(4): 1168-1178. doi: 10.1093/schbul/sbaa159
|
| [2] |
ZHANG X B, XIAO W H, CHEN K Y, et al. Decreased serum EGF in first-episode and chronic schizophrenia patients: negative correlation with psychopathology[J]. Sci Rep, 2020, 10(1): 6506. doi: 10.1038/s41598-020-63544-0
|
| [3] |
ZHANG X B, XIAO W H, CHEN K Y, et al. Serum epidermal growth factor is low in schizophrenia and not affected by antipsychotics alone or combined with electroconvulsive therapy[J]. Front Psychiatry, 2020, 11: 104.
|
| [4] |
MISIAK B, BARTOLI F, CARRÁ G, et al. Immune-inflammatory markers and psychosis risk: a systematic review and meta-analysis[J]. Psychoneuroendocrinology, 2021, 127: 105200. doi: 10.1016/j.psyneuen.2021.105200
|
| [5] |
NORTH H F, BRUGGEMANN J, CROPLEY V, et al. Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions[J]. Eur Arch Psychiatry Clin Neurosci, 2021, 271(4): 595-607. doi: 10.1007/s00406-021-01237-z
|
| [6] |
HAN R, ZHENG P Y, WANG J Q, et al. Desmoglein 3 gene mediates epidermal growth factor/epidermal growth factor receptor signaling pathway involved in inflammatory response and immune function of anaphylactic rhinitis[J]. Biomed Pharmacother, 2019, 118: 109214. doi: 10.1016/j.biopha.2019.109214
|
| [7] |
CHOI S Y, LEE Y J, KIM J M, et al. Epidermal growth factor relieves inflammatory signals in Staphylococcus aureus-treated human epidermal keratinocytes and atopic dermatitis-like skin lesions in nc/nga mice[J]. Biomed Res Int, 2018, 2018: 9439182.
|
| [8] |
NAWA H, TAKAHASHI M, PATTERSON P H. Cytokine and growth factor involvement in schizophrenia—support for the developmental model[J]. Mol Psychiatry, 2000, 5(6): 594-603. doi: 10.1038/sj.mp.4000730
|
| [9] |
周晓静, 贾晓菊. 精神分裂症与人类白细胞抗原介导自身免疫及其药物治疗研究[J]. 临床军医杂志, 2021, 49(5): 594-597. https://www.cnki.com.cn/Article/CJFDTOTAL-JYGZ202105042.htm
|
| [10] |
ANDREASEN N C, CARPENTER W T Jr, KANE J M, et al. Remission in schizophrenia: proposed criteria and rationale for consensus[J]. Am J Psychiatry, 2005, 162(3): 441-449. doi: 10.1176/appi.ajp.162.3.441
|
| [11] |
MAN L J, LV X L, DU X D, et al. Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia[J]. Psychiatry Res, 2018, 263: 1-6. doi: 10.1016/j.psychres.2018.02.034
|
| [12] |
于玲, 曾勇, 赵心灵, 等. 首发精神分裂症患者血清MIF、EGF水平与认知功能相关性[J]. 中华行为医学与脑科学杂志, 2018, 27(9): 793-797. doi: 10.3760/cma.j.issn.1674-6554.2018.09.005
|
| [13] |
SOTOYAMA H, NAMBA H, KOBAYASHI Y, et al. Resting-state dopaminergic cell firing in the ventral tegmental area negatively regulates affiliative social interactions in a developmental animal model of schizophrenia[J]. Transl Psychiatry, 2021, 11(1): 236. doi: 10.1038/s41398-021-01346-2
|
| [14] |
JODO E, INABA H, NARIHARA I, et al. Neonatal exposure to an inflammatory cytokine, epidermal growth factor, results in the deficits of mismatch negativity in rats[J]. Sci Rep, 2019, 9(1): 7503. doi: 10.1038/s41598-019-43923-y
|
| [15] |
GALVEZ-CONTRERAS A Y, CAMPOS-ORDONEZ T, LOPEZ-VIRGEN V, et al. Growth factors as clinical biomarkers of prognosis and diagnosis in psychiatric disorders[J]. Cytokine Growth Factor Rev, 2016, 32: 85-96. doi: 10.1016/j.cytogfr.2016.08.004
|
| [16] |
FUTAMURA T, KAKITA A, TOHMI M, et al. Neonatal perturbation of neurotrophic signaling results in abnormal sensorimotor gating and social interaction in adults: implication for epidermal growth factor in cognitive development[J]. Mol Psychiatry, 2003, 8(1): 19-29. doi: 10.1038/sj.mp.4001138
|
| [17] |
FOND G, DE VERVILLE P L S, RICHIERI R, et al. Redefining peripheral inflammation signature in schizophrenia based on the real-world FACE-SZ cohort[J]. Prog Neuropsychopharmacol Biol Psychiatry, 2021, 111: 110335. doi: 10.1016/j.pnpbp.2021.110335
|
| [18] |
HUI L, ZHANG X, YU Y Q, et al. Association between DBH 19 bp insertion/deletion polymorphism and cognition in first-episode schizophrenic patients[J]. Schizophr Res, 2013, 147(2/3): 236-240.
|
| [19] |
BALÕTSEV R, KOIDO K, VASAR V, et al. Inflammatory, cardio-metabolic and diabetic profiling of chronic schizophrenia[J]. Eur Psychiatry, 2017, 39: 1-10. doi: 10.1016/j.eurpsy.2016.05.010
|
| [20] |
KAMPMAN O, ANTTILA S, ILLI A, et al. Interaction of tumor necrosis alpha - G308A and epidermal growth factor gene polymorphisms in early-onset schizophrenia[J]. Eur Arch Psychiatry Clin Neurosci, 2005, 255(4): 279-283. doi: 10.1007/s00406-004-0560-8
|
| [21] |
SOCHETT E, NOONE D, GRATTAN M, et al. Relationship between serum inflammatory markers and vascular function in a cohort of adolescents with type 1 diabetes[J]. Cytokine, 2017, 99: 233-239. doi: 10.1016/j.cyto.2017.07.013
|
| [22] |
SU Y W, LUO H, YANG J X. Heparin-binding EGF-like growth factor attenuates lung inflammation and injury in a murine model of pulmonary emphysema[J]. Growth Factors, 2018, 36(5/6): 246-262.
|
| [23] |
KASZA A. IL-1 and EGF regulate expression of genes important in inflammation and cancer[J]. Cytokine, 2013, 62(1): 22-33. doi: 10.1016/j.cyto.2013.02.007
|
| [24] |
MISIAK B, STAÑCZYKIEWICZ B, KOTOWICZ K, et al. Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: a systematic review[J]. Schizophr Res, 2018, 192: 16-29. doi: 10.1016/j.schres.2017.04.015
|
| [25] |
BORA E. Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis[J]. Psychol Med, 2019, 49(12): 1971-1979. doi: 10.1017/S0033291719001685
|
| [26] |
高波, 王彦荣. 抗精神病药对精神分裂症患者血清脑源性神经营养因子水平与认知功能的影响[J]. 实用临床医药杂志, 2013, 17(17): 100-101. https://www.cnki.com.cn/Article/CJFDTOTAL-XYZL201317036.htm
|
© 2020 《实用临床医药杂志》编辑部
Address: 江苏省扬州市江阳中路136号，扬州大学江阳路北校区14号楼201室China Pos: 225009Tel: 0514-87978917、87978989、87978807
Supported by:
Beijing Renhe Information Technology Co., Ltd.
苏公网安备 32100302010246号
DownLoad: